AWP: Low Dose Atropine Study Discussion with Cheryl Chapman

Release Date:

Dr. Cheryl Chapman joins to discuss the recent atropine study published in JAMA: "Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control, A Randomized Clinical Trial" 
We also discuss best practices for improving patient communication and staff professional development including the Certified Myopia Manager Navigator certification for staff. Atropine is a great treatment option when managing children with myopia, and Dr. Cheryl Chapman discusses some of the studies, shares best practices and She has shared two different resources that she utilizes in her clinic and references during our discussion. Those can be found here:
Expected Axial Length Progression by Age
AAOMC Axial Length Graph
Dr. Cheryl Chapman has instituted a full-scope myopia management clinic within her practice and works tirelessly to spread myopia management knowledge. In addition to working one-on-one with doctors to implement practice protocols, she lectures within the optometric community as well as to local pediatricians and ophthalmologists. She is also the current president of the American Academy of Orthokeratology and Myopia Control. 

AWP: Low Dose Atropine Study Discussion with Cheryl Chapman

Title
AWP: Low Dose Atropine Study Discussion with Cheryl Chapman
Copyright
Release Date

flashback